Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
Rhea-AI Summary
MDxHealth (NASDAQ: MDXH) will release third quarter 2025 financial results for the period ended September 30, 2025 after market close on Wednesday, November 12, 2025.
The company will host a conference call and webcast with live Q&A on November 12, 2025 at 4:30 PM ET / 22:30 CET. Attendees are asked to access the webcast 15 minutes early. Dial-in numbers are provided for the United States, Belgium, the Netherlands, and the United Kingdom; the conference ID is 10203872. The live webcast URL is https://viavid.webcasts.com/starthere.jsp?ei=1738892&tp_key=76bbbf3f0a. A replay will be available on the company website following the call.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MDXH declined 1.63%, reflecting a mild negative market reaction. This price movement removed approximately $4M from the company's valuation, bringing the market cap to $236M at that time.
Data tracked by StockTitan Argus on the day of publication.
Mdxhealth to Release Third Quarter 2025 Financial Results
on November 12
Company to Host Conference Call with Live Q&A, November 12, 2025, at 4:30pm ET / 22:30 CET
IRVINE, California – November 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Wednesday, November 12, 2025.
| Title: | Mdxhealth Presents Third Quarter 2025 Financial Results and Corporate Update Conference Call and Webcast |
| Date: | November 12, 2025 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064 |
| Conference ID: | 10203872 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1738892&tp_key=76bbbf3f0a |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenomic, exosomal and other molecular signatures and assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Waltham, Massachusetts and Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
| For more information: ir@mdxhealth.com LifeSci Advisors (IR & PR) John Fraunces Managing Director Tel: +1 917 355 2395 Jfraunces@lifesciadvisors.com | |
Attachment
FAQ
When will MDxHealth (MDXH) release third quarter 2025 results?
What time is the MDxHealth (MDXH) Q3 2025 conference call and webcast?
How can investors join the MDxHealth (MDXH) webcast for the November 12, 2025 call?
What dial-in number and conference ID should I use for the MDxHealth (MDXH) November 12 call?
Will a replay be available after the MDxHealth (MDXH) November 12, 2025 webcast?
